Tori Kinamon

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Tufts University(Current)

Orthopaedic Research of Virginia

George Washington University

Clinical Research Institute

Emory University

Tori Kinamon is an author at Tufts University specializing in clinical trial efficacy endpoints, antimicrobial pharmacotherapy, and treatment strategies.

Publications per year

2022–2023

Publications

Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials

Jessica Howard‐Anderson, Toshimitsu Hamasaki, Weixiao Dai et al. · Clinical Infectious Diseases · 2022 · 39 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +13

Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs

Tori Kinamon, Ramya Gopinath, Ursula Waack et al. · Clinical Infectious Diseases · 2023 · 22 citations · Full text

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +14

Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Jessica Howard‐Anderson, Toshimitsu Hamasaki, Weixiao Dai et al. · Clinical Infectious Diseases · 2023 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

The Future Ain’t What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations

Scott Evans, Robin Patel, Toshimitsu Hamasaki et al. · Clinical Infectious Diseases · 2023 · 13 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +15

1–4 of 4